Stock Ideas
New
StocksFundsScreenerSectorsWatchlists

Latest Saturn V Capital Management LLC Stock Portfolio

$261Million

Equity Portfolio Value
Last Reported on: 14 Feb, 2024

About Saturn V Capital Management LLC and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Saturn V Capital Management LLC reported an equity portfolio of $238.9 Millions as of 30 Sep, 2023.

The top stock holdings of Saturn V Capital Management LLC are CRNX, KALV, COGT. The fund has invested 14% of it's portfolio in CRINETICS PHARMACEUTICALS IN and 7.3% of portfolio in KALVISTA PHARMACEUTICALS INC.

The fund managers got completely rid off CHINOOK THERAPEUTICS INC, APELLIS PHARMACEUTICALS INC (APLS) and SAGE THERAPEUTICS INC (SAGE) stocks. They significantly reduced their stock positions in MORPHIC HLDG INC (MORF) and CYMABAY THERAPEUTICS INC (CBAY). Saturn V Capital Management LLC opened new stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), ANAPTYSBIO INC (ANAB) and JASPER THERAPEUTICS INC (JSPR). The fund showed a lot of confidence in some stocks as they added substantially to SYNDAX PHARMACEUTICALS INC (SNDX), ARGENX SE and SAREPTA THERAPEUTICS INC (SRPT).

New Buys

Ticker$ Bought
APELLIS PHARMACEUTICALS INC8,555,610
DISC MEDICINE INC3,741,920
AMICUS THERAPEUTICS INC2,837,620
ALNYLAM PHARMACEUTICALS INC1,976,690
PHATHOM PHARMACEUTICALS INC1,461,480
AMBRX BIOPHARMA INC751,601

New stocks bought by Saturn V Capital Management LLC

Additions

Ticker% Inc.
MERUS N V871
ARGENX SE407
MORPHIC HLDG INC55.29
AMYLYX PHARMACEUTICALS INC24.05
ASCENDIS PHARMA A/S17.15
ANAPTYSBIO INC15.11
BIOMARIN PHARMACEUTICAL INC8.66

Additions to existing portfolio by Saturn V Capital Management LLC

Reductions

Ticker% Reduced
COGENT BIOSCIENCES INC-57.38
BIOGEN INC-49.8
SYNDAX PHARMACEUTICALS INC-35.79
CYMABAY THERAPEUTICS INC-33.28
CRINETICS PHARMACEUTICALS IN-30.13
ASTRIA THERAPEUTICS INC-18.74
ITEOS THERAPEUTICS INC-16.74
CYTOKINETICS INC-9.5

Saturn V Capital Management LLC reduced stake in above stock

Sold off


Saturn V Capital Management LLC got rid off the above stocks

Current Stock Holdings of Saturn V Capital Management LLC

Last Reported on: 14 Feb, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ALNYALNYLAM PHARMACEUTICALS INC0.7610,3271,976,690NEW
AMAMAMBRX BIOPHARMA INC0.2952,781751,601NEW
AMLXAMYLYX PHARMACEUTICALS INC6.191,099,27016,181,200ADDED24.05
ANABANAPTYSBIO INC5.45664,27614,228,800ADDED15.11
APLSAPELLIS PHARMACEUTICALS INC3.28142,9278,555,610NEW
ARGXARGENX SE7.4551,17519,468,500ADDED407
ASNDASCENDIS PHARMA A/S6.35131,75916,595,000ADDED17.15
ATXSASTRIA THERAPEUTICS INC2.91990,6637,608,290REDUCED-18.74
BCRXBIOCRYST PHARMACEUTICALS INC0.000.000.00SOLD OFF-100
BIIBBIOGEN INC3.2232,4698,402,000REDUCED-49.8
BMRNBIOMARIN PHARMACEUTICAL INC4.40119,18811,492,100ADDED8.66
CBAYCYMABAY THERAPEUTICS INC6.78750,25017,720,900REDUCED-33.28
COGTCOGENT BIOSCIENCES INC1.70756,6814,449,280REDUCED-57.38
CRNXCRINETICS PHARMACEUTICALS IN10.72787,13228,006,200REDUCED-30.13
CYTKCYTOKINETICS INC14.32448,14437,415,500REDUCED-9.5
FOLDAMICUS THERAPEUTICS INC1.09199,9732,837,620NEW
HZNPHORIZON THERAPEUTICS PUB L0.000.000.00SOLD OFF-100
ITOSITEOS THERAPEUTICS INC3.47828,2329,069,140REDUCED-16.74
JSPRJASPER THERAPEUTICS INC0.421,386,2201,093,720REDUCED-0.06
KALVKALVISTA PHARMACEUTICALS INC8.481,807,56022,142,600REDUCED-0.15
MORFMORPHIC HLDG INC2.35212,3436,132,470ADDED55.29
MRUSMERUS N V4.10389,33310,706,700ADDED871
PHATPHATHOM PHARMACEUTICALS INC0.56160,0751,461,480NEW
SNDXSYNDAX PHARMACEUTICALS INC4.29518,79911,211,200REDUCED-35.79
SRPTSAREPTA THERAPEUTICS INC0.000.000.00SOLD OFF-100
DISC MEDICINE INC1.4364,7843,741,920NEW